Text Size

Evaluation of a Patient Education Program for Ankylosing Spondylitis

This study has been completed.
Sponsor:
Collaborator:
Hannover Medical School
Information provided by:
Rehazentrum Bad Eilsen
ClinicalTrials.gov Identifier:
NCT00722514
First received: July 23, 2008
Last updated: August 14, 2008
Last verified: July 2008
History of Changes
  Purpose

Long term disease management is essential for Ankylosing Spondylitis (AS), a chronic progressive systemic inflammatory disease of the axial skeleton. Extensive information about the disease is a necessary first step. An education program for AS was implemented to improve inpatient medical rehabilitation. In a controlled quasi-experimental multicentric study the efficacy of this program was analysed.


Condition Intervention
Ankylosing Spondylitis
Spondyloarthritis
 Behavioral: patient education
Behavioral: Standard Care

Study Type: Interventional
Official Title: Evaluation of a Patient Education Program for Ankylosing Spondylitis

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Rehazentrum Bad Eilsen:

Study Start Date: July 1998
Estimated Study Completion Date: July 2001
Estimated Primary Completion Date: February 2001 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: IG
Patient education
 Behavioral: patient education
  • complex individual antiinflammatory rehabilitation program during inpatient rehabilitation (physiotherapy, physical therapy, occupational therapy, health-promoting measures and more) and additionally
  • Patient education 6 x 90 Minutes
CG
without patient education
 Behavioral: Standard Care
  • complex individual antiinflammatory rehabilitation program during inpatient
  • complex individual medical rehabilitation (physiotherapy, physical therapy, occupational therapy, health-promoting measures and more) and additionally
  • further 6 treatments from available disciplines(e.g. massage, electrotherapy, bath)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ankylosing Spondylitis (AS) according to modified New York Criteria
  • Early diagnosis criteria for AS
  • ESSG Criteria for Spondyloarthritis

Exclusion Criteria:

  • History of malignant disease during past five years
  • Secondary fibromyalgia syndrome
  • Group integration deficiencies
  • Seminar repeaters
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00722514

Locations
Germany
Rehazentrum Bad Eilsen
Bad Eilsen, Lower Saxony, Germany, 31707
Sponsors and Collaborators
Rehazentrum Bad Eilsen
Hannover Medical School
Investigators
Principal Investigator: Inge Ehlebracht-Koenig, MD Rehazentrum Bad Eilsen
  More Information

No publications provided

Responsible Party: Dr. Inge Ehlebracht-König, Rehazentrum Bad Eilsen
ClinicalTrials.gov Identifier: NCT00722514     History of Changes
Other Study ID Numbers: 0110599604
Study First Received: July 23, 2008
Last Updated: August 14, 2008
Health Authority: Germany: Ministry of Health

Additional relevant MeSH terms:
Spondylitis
Spondylitis, Ankylosing
Spondylarthritis
Bone Diseases, Infectious
Infection
Bone Diseases
 Musculoskeletal Diseases
Spinal Diseases
Spondylarthropathies
Ankylosis
Joint Diseases
Arthritis

ClinicalTrials.gov processed this record on May 23, 2013